Viatris (VTRS) Change in Taxes (2020 - 2026)
Viatris (VTRS) posted quarterly Change in Taxes of -$463.4 million for Q1 2026, down 284.25% year-over-year from $251.5 million in Q1 2025, and down 469.24% quarter-over-quarter from $125.5 million in Q4 2025.
Viatris (VTRS) Change in Taxes (2020 - 2026) Analysis & Trends
Viatris' Change in Taxes history runs 7 years deep, the most recent figure standing at -$463.4 million for Q1 2026.
- In Q1 2026, Change in Taxes fell 284.25% year-over-year to -$463.4 million; the TTM figure through Mar 2026 stood at -$455.7 million (down 551.19% YoY), while the FY2025 annual figure was -$112.9 million, down 151.48% from the prior year.
- Change in Taxes for Q1 2026 stood at -$463.4 million, down from $125.5 million in the prior quarter.
- The five-year high for Change in Taxes was $268.2 million in Q3 2024, with the low at -$463.4 million in Q1 2026.
- The 5-year median for Change in Taxes is -$4.2 million (2022), against an average of -$24.0 million.
- The sharpest annual moves came in 2024 and 2025: Change in Taxes surged 3676.0% in 2024, then plunged 5143.48% in 2025.
- Viatris' Change in Taxes stood at -$4.2 million in 2022, then tumbled by 1021.43% to -$47.1 million in 2023, then slumped by 43.52% to -$67.6 million in 2024, then soared by 285.65% to $125.5 million in 2025, then sank by 469.24% to -$463.4 million in 2026.
- Business Quant data shows VTRS's Change in Taxes at -$463.4 million in Q1 2026, $125.5 million in Q4 2025, and $128.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -106.03 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 40.90 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -59.60 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.90 Mn |
| Jun 30, 2026 | 40.90 Mn |
| Mar 31, 2026 | -463.40 Mn |
| Mar 31, 2026 | -463.40 Mn |
| Dec 31, 2025 | 125.50 Mn |
| Dec 31, 2025 | 125.50 Mn |
| Sep 30, 2025 | 128.20 Mn |
| Sep 30, 2025 | 128.20 Mn |
| Jun 30, 2025 | -246.00 Mn |
| Jun 30, 2025 | -246.00 Mn |
| Mar 31, 2025 | -120.60 Mn |
| Mar 31, 2025 | -120.60 Mn |
| Dec 31, 2024 | -67.60 Mn |
| Dec 31, 2024 | -67.60 Mn |
| Sep 30, 2024 | 268.20 Mn |
| Sep 30, 2024 | 268.20 Mn |
| Jun 30, 2024 | 21.00 Mn |
| Jun 30, 2024 | 21.00 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Mar 31, 2024 | -2.30 Mn |